About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us
> Real-time Quotes & News

Real-time Quotes

Product
Bid
Ask
High
Low
Previous Close
*The above quotes are for reference only

Real-time News

2026-09-22

European Commission Vice President Šefčovič said trade still has substantial room to grow and could be far higher than current levels.

European Commission Vice President Šefčovič said trade still has substantial room to grow and could be far higher than current levels.
2026-09-22

European Commission Vice-President Šefčovič: There is still much room for trade to grow, far exceeding current levels.

European Commission Vice-President Šefčovič: There is still much room for trade to grow, far exceeding current levels.
2026-09-22

Novo Nordisk's CEO said the company must do more to rebuild investor trust as flagship drugs including Ozempic and Wegovy face patent expiries in the US and Europe over the next decade. He warned that overpromising and under-delivering quickly erodes

Novo Nordisk's CEO said the company must do more to rebuild investor trust as flagship drugs including Ozempic and Wegovy face patent expiries in the US and Europe over the next decade. He warned that overpromising and under-delivering quickly erodes confidence and that investors want clarity on the company's next steps. Shares fell on Monday after an investor day disappointed with limited detail on the turnaround plan. Ozempic and Wegovy account for roughly three-quarters of sales. Novo Nordisk has pledged to launch more than five major drugs by 2030 and to add over $23 bln in incremental sales by 2035; analysts say those targets largely meet expectations. BMO Capital Markets said the company remains in a proof-of-performance phase and investors need clearer visibility on next-generation drugs and likely market uptake to restore confidence.
2026-09-22

Morgan Stanley points out that the combined return on incremental invested capital (ROIIC) for major hyperscale cloud vendors such as Amazon, Alphabet, Microsoft, Meta, and Oracle is expected to bottom out in the third quarter of 2027, falling to app

Morgan Stanley points out that the combined return on incremental invested capital (ROIIC) for major hyperscale cloud vendors such as Amazon, Alphabet, Microsoft, Meta, and Oracle is expected to bottom out in the third quarter of 2027, falling to approximately 23%. Market consensus anticipates that this metric will steadily recover after bottoming out, rebounding to approximately 35% by 2030. The core implication is that the current large-scale capital expenditures on AI data centers and computing infrastructure may temporarily suppress the return on new capital in the coming years, but market consensus does not believe this pressure will be long-term. As AI-related investments gradually translate into revenue and profit, the ROIIC for hyperscale cloud vendors is expected to improve again after 2027.
2026-09-22

European stocks opened steady as investors awaited potential US-Iran talks during this week’s UN General Assembly. Additional oil flows via the Strait of Hormuz resumed over the weekend. Oil prices posted their first gain after five consecutive sessi

European stocks opened steady as investors awaited potential US-Iran talks during this week’s UN General Assembly. Additional oil flows via the Strait of Hormuz resumed over the weekend. Oil prices posted their first gain after five consecutive sessions of decline, and energy shares rose 0.4%.
2026-09-22

Daiwa raised its target price for Biren Technology (06082.HK) to HK$130 from HK$100 and reiterated a Buy, after management lifted 2027 revenue guidance to yuan 20 billion from yuan 10 billion. Daiwa said the revision reflects higher average selling p

Daiwa raised its target price for Biren Technology (06082.HK) to HK$130 from HK$100 and reiterated a Buy, after management lifted 2027 revenue guidance to yuan 20 billion from yuan 10 billion. Daiwa said the revision reflects higher average selling prices for mainstream Chinese AI chips and a bigger revenue mix from super‑pod solutions, signaling confidence in the flagship BR20x chip and order pickup. The broker raised its 2026–28 revenue forecasts by 14%, 94% and 58% to yuan 2.408bn, yuan 21.008bn and yuan 45.508bn, and upped 2027–28 net profit forecasts by 35% and 10% to yuan 4.179bn and yuan 11.967bn. The new PT implies roughly 15x 2027 price-to-sales.
Previous 1 ... 295 296 297 298 299 ... 302 Next
Real-time Quotes
Real-time News
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.